GlassScriptPhysician profile
Cameron John Kurowski
NPI 1174584437
$1,810.25
in general payments reported to CMS, 2019-2025
30 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $155 · 2021: $300 · 2022: $163 · 2023: $180 · 2024: $357 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $217.93 | 2019-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $189.48 | 2019-2025 | |
| Glaxosmithkline, LLC. | $179.59 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $145.30 | 2019-2025 | |
| Novo Nordisk INC | $133.83 | 2019-2024 | Rybelsus, Ozempic |
| Ironwood Pharmaceuticals, INC | $107.93 | 2020-2023 | Linzess |
| Astrazeneca Pharmaceuticals LP | $88.85 | 2019-2024 | Farxiga, Nexium |
| Corcept Therapeutics | $87.41 | 2024-2025 | Korlym |
| Abbott Laboratories | $86.18 | 2019-2024 | Octrode, Freestyle Libre 3 |
| Radius Health, INC. | $55.81 | 2022-2025 | Tymlos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.48 | 2022-2024 | Xifaxan |
| Exact Sciences Corporation | $49.74 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $45.89 | 2019-2022 | |
| Inari Medical, INC. | $43.33 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.81 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $37.94 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.78 | 2021-2023 | Trintellix |
| Allergan, INC. | $23.97 | 2019 | |
| Avanir Pharmaceuticals, INC. | $23.83 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $23.36 | 2019 | |
| Medtronic, INC. | $18.46 | 2025 | Intellis Adaptivestim |
| Novartis Pharmaceuticals Corporation | $17.13 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.21 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $16.16 | 2021 | |
| Boston Scientific Corporation | $15.25 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.03 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $14.61 | 2024 | Evkeeza |
| Eisai INC. | $14.58 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.21 | 2019 | |
| Merck Sharp & Dohme LLC | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Kurowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.